https://www.selleckchem.com/pr....oducts/Novobiocin-so
However, high heterogeneity (superior to 60%) was observed for all outcomes. Results support a reduction in diabetic LEA frequency in association with structured diabetic foot care, and, in particular, major LEA. Less evidence is available for the remaining aspects of diabetic foot care delivery. Results support a reduction in diabetic LEA frequency in association with structured diabetic foot care, and, in particular, major LEA. Less evidence is available for the remaining aspects of diabetic foot care delivery. Si